Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study

NCT02128139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-05-22

No results posted yet for this study

Summary

Introduction. Comprehensive data on infective endocarditis in developing countries are scarce.

Objectives: Description of the characteristics (clinical and microbiological) and assessment of the outcomes of infective endocarditis in low-income countries.

Methods : Prospective, Observational, Multicentre study. Inclusion criteria: patients aged over 1 year fulfilling the modified Duke criteria for infective endocarditis.

Exclusion criteria: patient included during a previous infective endocarditis episode.

Outcomes measures: Mortality at 6 months follow-up; mortality at 1 month follow-up; access to antibiotic treatment (modalities and duration), hospital length of stay and reason for discharge, and cardiac surgery when indicated.

Duration: One year (June 2014- June 2015)

Conditions

  • Infective Endocarditis

Sponsors & Collaborators

  • War Memorial Hospital

    collaborator OTHER
  • Centers for Disease Control and Prevention

    collaborator FED
  • Oxford University Hospitals NHS Trust

    collaborator OTHER
  • St. Elizabeth Catholic General Hospital Shisong, Cameroun

    collaborator UNKNOWN
  • CHU de Brazzaville, Congo Brazzaville

    collaborator UNKNOWN
  • Polyclinique International de Bamako, Mali

    collaborator UNKNOWN
  • CHR de Saint-Louis Lt Colonel Mamadou Diouf, Sénégal

    collaborator UNKNOWN
  • Hôpital Général de Grand Yoff de Dakar, Sénégal

    collaborator UNKNOWN
  • Bafoussam Regional Hospital, Cameroon

    collaborator UNKNOWN
  • Hospital Laquinitinie de Douala

    collaborator UNKNOWN
  • Yaounde Central Hospital

    collaborator OTHER_GOV
  • National Hospital of Niamey

    collaborator OTHER
  • Centre National Hospitalier Universitaire de Pneumo-Phtisiologie de Cotonou, Benin

    collaborator UNKNOWN
  • Hospital General De Douala

    collaborator OTHER
  • Eduardo Mondlane University

    collaborator OTHER
  • Laos Oxford Mahosot Wellcome Research Unit

    collaborator UNKNOWN
  • Mulago Hospital, Uganda

    collaborator OTHER
  • Fann Hospital, Senegal

    collaborator UNKNOWN
  • Institute of Cardiology Abidjan

    collaborator UNKNOWN
  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-04-30
Completion
2015-10-31

Countries

  • Fiji
  • Laos
  • Mozambique
  • Senegal
  • Uganda

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02128139 on ClinicalTrials.gov